Real-time enrollment status for this alcohol-associated liver disease clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 10:17 AM UTC
| NCT Number | NCT07009860 |
| Recruiting Status | Recruiting |
| Condition | Alcohol-Associated Liver Disease |
| Phase | PHASE2 |
| Target Enrollment | 100 participants |
| Active Locations | 42 sites in the US |
| Sponsor | Altimmune, Inc. |
| Last Updated on CT.gov | March 20, 2026 (Mar 20, 2026) |
As of July 18, 2026: Clinical trial NCT07009860 is currently recruiting participants. This phase2 study for alcohol-associated liver disease is actively seeking new participants at 42 locations across the United States. The study is sponsored by Altimmune, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07009860 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 42 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07009860 was last updated Mar 20, 2026 (March 20, 2026). HelloStudys verifies this status automatically.